sitagliptin / metformin hydrochloride mylan
mylan ireland limited - sitagliptin hydrochloride monohydrate, metformin hydrochloride - diabetes mellitus, tipo 2 - drogas usadas en diabetes - for adult patients with type 2 diabetes mellitus:sitagliptin/metformin hydrochloride mylan is indicated as an adjunct to diet and exercise to improve glycaemic control in patients inadequately controlled on their maximal tolerated dose of metformin alone or those already being treated with the combination of sitagliptin and metformin. sitagliptin/metformin hydrochloride mylan is indicated in combination with a sulphonylurea (i. , terapia de combinación triple) como complemento a la dieta y ejercicio en pacientes inadecuadamente controlados en su máxima dosis tolerada de metformina y una sulfonilurea. sitagliptin/metformin hydrochloride mylan is indicated as triple combination therapy with a peroxisome proliferator-activated receptor gamma (pparg) agonist (i. , a thiazolidinedione) as an adjunct to diet and exercise in patients inadequately controlled on their maximal tolerated dose of metformin and a pparg agonist. sitagliptin/metformin hydrochloride mylan is also indicated as add-on to insulin (i. , triple combination therapy) as an adjunct to diet and exercise to improve glycaemic control in patients when stable dose of insulin and metformin alone do not provide adequate glycaemic control.
sitagliptin / metformin hydrochloride accord
accord healthcare s.l.u. - metformin hydrochloride, sitagliptin hydrochloride monohydrate - diabetes mellitus, tipo 2 - drogas usadas en diabetes - for adult patients with type 2 diabetes mellitus:it is indicated as an adjunct to diet and exercise to improve glycaemic control in patients inadequately controlled on their maximal tolerated dose of metformin alone or those already being treated with the combination of sitagliptin and metformin. it is indicated in combination with a sulphonylurea (i. , terapia de combinación triple) como complemento a la dieta y ejercicio en pacientes inadecuadamente controlados en su máxima dosis tolerada de metformina y una sulfonilurea. it is indicated as triple combination therapy with a peroxisome proliferator-activated receptor gamma (pparγ) agonist (i. , a thiazolidinedione) as an adjunct to diet and exercise in patients inadequately controlled on their maximal tolerated dose of metformin and a pparγ agonist. it is also indicated as add-on to insulin (i. , triple combination therapy) as an adjunct to diet and exercise to improve glycaemic control in patients when stable dose of insulin and metformin alone do not provide adequate glycaemic control.
sitagliptina cinfamed 100 mg comprimidos recubiertos con pelicula efg
laboratorios cinfa s.a. - sitagliptina hidrocloruro - comprimido recubierto con pelÍcula - 100 mg - sitagliptina hidrocloruro 100 mg - sitagliptina
sitagliptina cinfamed 50 mg comprimido recubierto con pelicula efg
laboratorios cinfa s.a. - sitagliptina hidrocloruro - comprimido recubierto con pelÍcula - 50 mg - sitagliptina hidrocloruro 50 mg - sitagliptina
sitagliptina cinfamed 25 mg comprimido recubierto con pelicula efg
laboratorios cinfa s.a. - sitagliptina hidrocloruro - comprimido recubierto con pelÍcula - 25 mg - sitagliptina hidrocloruro 25 mg - sitagliptina
sitagliptina sandoz farmaceutica 100 mg comprimidos recubiertos con pelicula efg
sandoz farmaceutica s.a. - sitagliptina hidrocloruro monohidrato - comprimido recubierto con pelÍcula - 100 mg - sitagliptina hidrocloruro monohidrato 100 mg - sitagliptina
sitagliptina sandoz farmaceutica 50 mg comprimidos recubiertos con pelicula efg
sandoz farmaceutica s.a. - sitagliptina hidrocloruro monohidrato - comprimido recubierto con pelÍcula - 50 mg - sitagliptina hidrocloruro monohidrato 50 mg - sitagliptina
sitagliptina sandoz farmaceutica 25 mg comprimidos recubiertos con pelicula efg
sandoz farmaceutica s.a. - sitagliptina hidrocloruro monohidrato - comprimido recubierto con pelÍcula - 25 mg - sitagliptina hidrocloruro monohidrato 25 mg - sitagliptina
sitagliptina stada 25 mg comprimidos recubiertos con pelicula efg
laboratorio stada s.l. - sitagliptina hidrocloruro - comprimido recubierto con pelÍcula - 25 mg - sitagliptina hidrocloruro 25 mg - sitagliptina
sitagliptina stada 100 mg comprimidos recubiertos con pelicula efg
laboratorio stada s.l. - sitagliptina hidrocloruro - comprimido recubierto con pelÍcula - 100 mg - sitagliptina hidrocloruro 100 mg - sitagliptina